Gliomatosis cerebri epidemiology and demographics
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri epidemiology and demographics |
|
Gliomatosis cerebri epidemiology and demographics in the news |
|
Risk calculators and risk factors for Gliomatosis cerebri epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1] Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2] The median age at diagnosis is 34 years.[3] Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.[2]
Epidemiology and Demographics
Incidence
- Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1]
Age
- Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2]
- The median age at diagnosis is 34 years.[3]
Gender
- Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.[2]
References
- ↑ 1.0 1.1 Gliomatosis cerebri international registry. http://gcregistry.com/
- ↑ 2.0 2.1 2.2 2.3 Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
- ↑ 3.0 3.1 Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH; et al. (1998). "Gliomatosis cerebri: clinical features, treatment, and prognosis". Acta Neurochir (Wien). 140 (8): 755–62. PMID 9810441.